Patent details

EP1962903 Title: COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLTL ANTAGONIST FOR TREATING CANCER

Basic Information

Publication number:
EP1962903
PCT Application Number:
PCT/GB/2006/004611
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP068204767
PCT Publication Number:
WO/2007/068895
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLTL ANTAGONIST FOR TREATING CANCER
French Title of Invention:
COMBINAISON D'UN ANTAGONISTE DE L'ANGIOPOIETINE 2 ET D'UN ANTAGONISTE DU VEGF-A ET/OU DU KDR ET/OU DU FLTL POUR LE TRAITEMENT DU CANCER
German Title of Invention:
KOMBINATION EINES ANGIOPOETIN-2-ANTAGONISTEN UND EINES VEGF-A, KDR- UND/ODER FLTL-ANTAGONISTEN ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
12/12/2006
Grant date:
13/03/2013
EP Publication Date:
13/03/2013
PCT Publication Date:
21/06/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/09/2008
EP B1 Publication Date:
13/03/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/12/2013
Expiration date:
12/12/2026
Renunciation date:
Revocation date:
Annulment date:

Inventor

1

Name:
BLAKEY David, Charles
Address:
United Kingdom (GB)

2

Name:
EMERY Stephen, Charles
Address:
United Kingdom (GB)

3

Name:
BROWN Jeffrey, Lester
Address:
United States (US)

Priority

Priority Number:
750551 P
Priority Date:
15/12/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/22;
Filing date Document type Number of pages